While the formulation patent for oral Wegovy remains valid in major markets such as the United States, the European Union, and Japan until 2039, the company explains that it can circumvent this through its proprietary formulation technology S-PASS. Ildong Pharmaceutical has also set a plan to achieve both technology licensing and entry into Phase 2 clinical trials this year for ID110521156, an oral GLP-1based new drug candidate
Wellness IV Therapy Our IV therapy delivers essential vitamins, minerals, and nutrients directly into your bloodstream, helping you achieve optimal wellness, boost recovery, and enhance your vitality
Ozempic, the brand name for semaglutide, has gained widespread use in managing type 2 diabetes and promoting weight loss
As we talk about MS, as we talk about autoimmune diseases, they do predominantly affect women
Yawalkar N